| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JAZZ | Ordinary Shares | Award | $0 | +7,506 | +12% | $0.000000 | 69,947 | 17 Jan 2025 | Direct | F1, F2 |
| transaction | JAZZ | Ordinary Shares | Tax liability | $267,434 | -2,181 | -3.1% | $122.62 | 67,766 | 17 Jan 2025 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified. |
| F2 | The Reporting Person acquired 167 ordinary shares on May 31, 2024 and 48 ordinary shares on November 29, 2024 under a Section 423 Employee Stock Purchase Plan. |
| F3 | Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations. |